EUVIMEDEUVIMED entdecken
Crossref

Creating a Novel Liquid Biopsy Using Exosomes: A Platform for Immunological Biomarker Discovery

Jack J. Scala, Michael Snyder, Matthew Joshua Frank, Or Gozani, Stanford University, Department of Biology

Stanford Digital Repository · 02.05.2024

DOI: 10.25740/mx526yw0359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stanford Digital Repository, erschienen am 02.05.2024. Verfasst von Jack J. Scala und 5 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric Antigen Receptor (CAR) T cell therapies have proven efficacious for patients with chemotherapy-refractory cancers. However, due to the transactivation of various immune cells and the development of a hyper-inflammatory disease state, many patients experience life-threatening complications post-CAR-T cell therapy, such as immune effector cell associated neurotoxicity syndrome (ICANS), immune effector cell associated hemophagocytic lymphohistiocytosis (IEC-HS), and cytokine release syndrome (CRS). There is a strong clinical need to identify robust biomarkers that enable the early diagnosis and treatment of this emerging class of immune-effector induced conditions. In this thesis, I propose a novel platform for the identification of robust and specific immune-cell-related biomarkers using exosomes, a subclass of extracellular vesicles, isolated from patient plasma samples. Specifically, the present work aims to develop and characterize a novel liquid biopsy capable of isolating T-cell, natural killer cell, and macrophage derived exosomes from a 1 mL sample of plasma, which is feasibly implementable in clinical workflows. By characterizing the isolated morphology, size range, and protein contents of isolated vesicles, I demonstrate that my proposed method isolates exosomes with greater purity than current isolation methods, including ultracentrifugation and size exclusion chromatography, and serves as a feasible method of identifying cytokine cargo in exosomes. With further optimization, we expect this can be developed into a potential clinical test of immune-effector adverse conditions.

Schlagwörter

exosomesliquid biopsyCAR T-cell therapyimmune effector cell-associated neurotoxicity syndromehemophagocytic lymphohistiocytosiscytokine release syndromebiomarker discoveryexosome isolationplasma exosomesmacrophage-derived exosomes

Zitieren

APA

Scala, J. J., Snyder, M., Frank, M. J., Gozani, O., University, S., & Biology, D. O. (2024). Creating a Novel Liquid Biopsy Using Exosomes: A Platform for Immunological Biomarker Discovery. Stanford Digital Repository. https://doi.org/10.25740/mx526yw0359

Vancouver

Scala JJ, Snyder M, Frank MJ, Gozani O, University S, Biology DO. Creating a Novel Liquid Biopsy Using Exosomes: A Platform for Immunological Biomarker Discovery. Stanford Digital Repository. 2024. doi:10.25740/mx526yw0359

BibTeX
@article{Scala2024,
  author = {Scala, Jack J. and Snyder, Michael and Frank, Matthew Joshua and Gozani, Or and University, Stanford and Biology, Department of},
  title = {Creating a Novel Liquid Biopsy Using Exosomes: A Platform for Immunological Biomarker Discovery},
  journal = {Stanford Digital Repository},
  year = {2024},
  doi = {10.25740/mx526yw0359}
}
Kostenlos starten →